Session Details
[JS02☆]Bringing Academia-Originated DDS Technologies to Practical Application through Industry–Academia Collaboration
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 05 (F401)
Organizer: Yusuke Kono (Kobe Pharm Univ.), Kazushi Okada (Shionogi Pharma)
Co-sponsored by:
The Pharmaceutical Society of Japan,
The Academy of Pharmaceutical Science and Technology, Japan
The Pharmaceutical Society of Japan,
The Academy of Pharmaceutical Science and Technology, Japan
オーガナイザー挨拶、趣旨説明
河野 裕允(神戸薬大)
[JS02-1]The challenge of creating nucleic acid drugs based on LNP technology
○Tomohiro Asai1,2 (1. Univ. of Shizuoka, 2. Luna RD)
[JS02-2]The challenge of human genome writing technology for drug development
○Yasunori Aizawa1,2,3 (1. Science Tokyo, School of Life Science and Technology, 2. Kanagawa Institute of Science and Technology, 3. Logomix)
[JS02-3]Immune cell-targeted nanoparticulate DDS technology fostered by medical–engineering and academia–industry collaboration for next gen drug discovery research
○Naozumi Harada1 (1. United Immunity)
[JS02-4]Development of platelet aggregating agent - from lab benches to investigational drug manufacturing -
○Susumu Sugiyama1, Hiroki Shirai1, Takayuki Kanzaki1 (1. Nobelpharma)
[JS02-5]Pharmaceutical Pioneers: Bridging the Gap from Academic Innovation to Real-World Application
○Shingo Arioka1 (1. SHIONOGI)
